Association between IL-32 genotypes and outcome in infection-associated acute lung injury

Critical Care

Volumn 15, Issue 3, 2011, Pages

  Arcaroli, John J ^a   Liu, Nianjun ^b   Yi, Nengjun ^b   Abraham, Edward ^c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 32; IL32 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ACUTE LUNG INJURY; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HUMAN; HYPOTENSION; INFECTION; INTRON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VENTILATOR; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ACUTE LUNG INJURY; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFECTION; INTERLEUKINS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79957955444     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10258     Document Type: Article

References (41)

1. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 1994, 271:226-233. 10.1001/jama.271.3.226, 8080494.
2. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992, 216:117-134. 10.1097/00000658-199208000-00002, 1242583, 1503516.
3. Abraham E, Kaneko DJ, Shenkar R. Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation. Am J Physiol 1999, 276:L1-8.
4. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996, 157:1630-1637.
5. Cassatella MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995, 16:21-26. 10.1016/0167-5699(95)80066-2, 7880385.
6. Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, Ghezzi P. Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med 1994, 123:394-399.
7. Gatti S, Faggioni R, Echtenacher B, Ghezzi P. Role of tumour necrosis factor and reactive oxygen intermediates in lipopolysaccharide-induced pulmonary oedema and lethality. Clin Exp Immunol 1993, 91:456-461. 1554720, 8443968.
8. Parsey MV, Tuder RM, Abraham E. Neutrophils are major contributors to intraparenchymal lung IL-1 beta expression after hemorrhage and endotoxemia. J Immunol 1998, 160:1007-1013.
9. Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005, 33:319-327. 10.1165/rcmb.F305, 2715340, 16172252.
10. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005, 22:131-142.
11. Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci USA 2005, 102:16309-16314. 10.1073/pnas.0508237102, 1283464, 16260731.
12. Nold-Petry CA, Nold MF, Zepp JA, Kim SH, Voelkel NF, Dinarello CA. IL-32-dependent effects of IL-1beta on endothelial cell functions. Proc Natl Acad Sci USA 2009, 106:3883-3888. 10.1073/pnas.0813334106, 2656174, 19228941.
13. Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, Sfriso P, Balestro E, Dinarello C, Saetta M. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 178:894-901. 10.1164/rccm.200804-646OC, 18703789.
14. Sorrentino C, Di Carlo E. Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 2009, 180:769-779. 10.1164/rccm.200903-0400OC, 19628777.
15. Seo EH, Kang J, Kim KH, Cho MC, Lee S, Kim HJ, Kim JH, Kim EJ, Park DK, Kim SH, Choi YK, Kim JM, Hong JT, Yoon DY, Eun-Hee S, Kang J, Ki KH. Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J Microbiol Biotechnol 2008, 18:1606-1612.
16. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007, 149:480-486. 10.1111/j.1365-2249.2007.03439.x, 2219317, 17590175.
17. Shoda H, Fujio K, Yamamoto K. Rheumatoid arthritis and interleukin-32. Cell Mol Life Sci 2007, 64:2671-2679. 10.1007/s00018-007-7186-8, 17619821.
18. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006, 103:3298-3303. 10.1073/pnas.0511233103, 1413916, 16492735.
19. Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur Cytokine Netw 2005, 16:289-292.
20. Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, Kim SJ, Kim SY. Identification of the most active interleukin-32 isoform. Immunology 2009, 126:535-542. 10.1111/j.1365-2567.2008.02917.x, 2673365, 18771438.
21. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351:327-336.
22. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 2002, 11:2463-2468. 10.1093/hmg/11.20.2463, 12351582.
23. Zeng ZB, Wang T, Zou W. Modeling quantitative trait Loci and interpretation of models. Genetics 2005, 169:1711-1725. 1449562, 15654105.
24. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006, 7:781-791. 10.1038/nrg1916, 16983374.
25. Yi N, Banerjee S. Hierarchical generalized linear models for multiple quantitative trait locus mapping. Genetics 2009, 181:1101-1113. 10.1534/genetics.108.099556, 2651046, 19139143.
26. Yi N, Kaklamani VG, Pasche B. Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk. Ann Hum Genet 2011, 75:90-104. 10.1111/j.1469-1809.2010.00605.x, 20846215.
27. Gelman A JA, Pittau MG, Su YS. A weakly informative default prior distribution for logistic and other regression models. Annals of Applied Statistics 2008, 2:1360-1383.
28. Allen AS, Satten GA. A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease. Genet Epidemiol 2009, 33:657-667. 10.1002/gepi.20417, 19365859.
29. Hong J, Bae S, Kang Y, Yoon D, Bai X, Chan ED, Azam T, Dinarello CA, Lee S, Her E, Rhof G, Kim S. Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNF[alpha] and IL-1[beta]. Cytokine 2010, 49:171-176. 10.1016/j.cyto.2009.10.003, 19880327.
30. Barksby HE, Nile CJ, Jaedicke KM, Taylor JJ, Preshaw PM. Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide. Clin Exp Immunol 2009, 156:479-487. 10.1111/j.1365-2249.2009.03920.x, 2691977, 19438601.
31. Kobayashi H, Lin PC. Molecular characterization of IL-32 in human endothelial cells. Cytokine 2009, 46:351-358. 10.1016/j.cyto.2009.03.007, 2704890, 19364659.
32. Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006, 65:iii61-iii64. 10.1136/ard.2006.058511, 1798381, 17038476.
33. Kobayashi H, Huang J, Ye F, Shyr Y, Blackwell TS, Lin PC. Interleukin-32β propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS ONE 2010, 5:e9458. 10.1371/journal.pone.0009458, 2832764, 20221440.
34. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003, 31:S195-199. 10.1097/01.CCM.0000057843.47705.E8, 12682440.
35. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-1564. 10.1016/S0140-6736(07)60604-7, 17482987.
36. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349. 10.1056/NEJM200005043421806, 10793167.
37. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992, 145:1016-1022.
38. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S, Morishita Y. Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med 2001, 29:628-634. 10.1097/00003246-200103000-00029, 11373433.
39. Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW. Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol 2006, 291:L1267-L1276. 10.1152/ajplung.00097.2006, 16861384.
40. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF. Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 2001, 163:1591-1598.
41. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137:288-296. 10.1378/chest.09-1484, 2816641, 19858233.